• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经口无切口胃底折叠术（TIF）——胃食管反流病外科治疗的新范例。

Transoral incision free fundoplication (TIF) - A new paradigm in the surgical treatment of GERD.

作者信息

Yushuva Arthur, McMahon Michael, Goodman Elliot

机构信息

Beth Israel Medical Centre, New York, USA.

Nuffield Leeds Hospital, Leeds, UK.

出版信息

J Surg Case Rep. 2010 Jul 1;2010(5):1. doi: 10.1093/jscr/2010.5.1.

DOI:10.1093/jscr/2010.5.1
PMID:24946319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3649125/
Abstract

An estimated 10 billion dollars is spent treating gastro-oesophageal reflux disease (GERD) in the USA every year. The present article reports a case of the safe and successful use of transoral incisionless fundoplication (TIF) using the EsophyX90™ device in the surgical treatment of GERD.

摘要

在美国，每年治疗胃食管反流病（GERD）的花费估计达100亿美元。本文报告了一例在GERD外科治疗中使用EsophyX90™设备安全成功进行经口无切口胃底折叠术（TIF）的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/13416dd978a2/jscr-2010-5-1fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/7a71920be725/jscr-2010-5-1fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/c94a119d3e9f/jscr-2010-5-1fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/13416dd978a2/jscr-2010-5-1fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/7a71920be725/jscr-2010-5-1fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/c94a119d3e9f/jscr-2010-5-1fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d24/3649125/13416dd978a2/jscr-2010-5-1fig3.jpg

相似文献

1
Transoral incision free fundoplication (TIF) - A new paradigm in the surgical treatment of GERD.经口无切口胃底折叠术（TIF）——胃食管反流病外科治疗的新范例。
J Surg Case Rep. 2010 Jul 1;2010(5):1. doi: 10.1093/jscr/2010.5.1.
2
Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.经口无切口胃底折叠术（TIF）治疗胃食管反流病（GERD）的疗效：一项荟萃分析的系统评价
Surg Endosc. 2017 Mar;31(3):1032-1044. doi: 10.1007/s00464-016-5111-7. Epub 2016 Aug 5.
3
Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.使用Esophyx（Tif 2.0）经口无切口胃底折叠术的长期疗效及影响胃食管反流病患者长达6年随访结果的因素：一项前瞻性单中心研究
Surg Endosc. 2015 Sep;29(9):2770-80. doi: 10.1007/s00464-014-4008-6. Epub 2014 Dec 6.
4
Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication.通过后续的腹腔镜nissen胃底折叠术对失败的经口无切口胃底折叠术进行翻修。
World J Gastroenterol. 2014 Dec 7;20(45):17115-9. doi: 10.3748/wjg.v20.i45.17115.
5
A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.接受经口无切口胃底折叠术的慢性胃食管反流病患者的前瞻性多中心登记研究。
J Am Coll Surg. 2012 Dec;215(6):794-809. doi: 10.1016/j.jamcollsurg.2012.07.014. Epub 2012 Aug 29.
6
Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.经口无切口胃底折叠术（TIF 2.0）联合 EsophyX 治疗胃食管反流病：长期结果及影响结局的发现。
Surg Endosc. 2012 May;26(5):1425-35. doi: 10.1007/s00464-011-2050-1. Epub 2011 Dec 15.
7
Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.使用Esophyx装置经口无切口胃底折叠术治疗对药物治疗有反应的胃食管反流病的长期益处。
Dis Esophagus. 2017 Feb 1;30(3):1-8. doi: 10.1111/dote.12525.
8
Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.随机临床试验：经口无切口胃底折叠术与假干预对照治疗慢性胃食管反流病
Aliment Pharmacol Ther. 2015 Dec;42(11-12):1261-70. doi: 10.1111/apt.13427. Epub 2015 Oct 13.
9
Transoral Incisionless Fundoplication TIF 2.0 with "EsophyX Z®" Device for GERD: Seven Years after Endo Lumenal Fundoplication. World’s First Case Report.使用“EsophyX Z®”设备进行经口无切口胃底折叠术（TIF 2.0）治疗胃食管反流病（GERD）：腔内胃底折叠术后七年。世界首例病例报告。
Chirurgia (Bucur). 2018 Nov-Dec;113(6):849-856. doi: 10.21614/chirurgia.113.6.849.
10
Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.腹腔镜 Nissen 胃底折叠术与经口无切口胃底折叠术或质子泵抑制剂治疗胃食管反流病的疗效比较：系统评价和网络荟萃分析。
Gastroenterology. 2018 Apr;154(5):1298-1308.e7. doi: 10.1053/j.gastro.2017.12.021. Epub 2018 Jan 3.

引用本文的文献

1
The evolution of TIF: transoral incisionless fundoplication.经口无切口胃底折叠术的发展历程：经口无切口胃底折叠术
Therap Adv Gastroenterol. 2020 May 21;13:1756284820924206. doi: 10.1177/1756284820924206. eCollection 2020.

本文引用的文献

1
Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.使用EsophyX进行抗反流经口无切口胃底折叠术的可行性研究的两年结果。
Surg Endosc. 2009 May;23(5):957-64. doi: 10.1007/s00464-009-0384-8. Epub 2009 Mar 14.
2
Medical treatments in the short term management of reflux oesophagitis.反流性食管炎短期治疗中的医学疗法。
Cochrane Database Syst Rev. 2007 Apr 18(2):CD003244. doi: 10.1002/14651858.CD003244.pub2.
3
Time trends of gastroesophageal reflux disease: a systematic review.胃食管反流病的时间趋势：一项系统综述
Clin Gastroenterol Hepatol. 2007 Jan;5(1):17-26. doi: 10.1016/j.cgh.2006.09.016. Epub 2006 Dec 4.
4
Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.用于反流性食管炎维持治疗和内镜阴性反流病的医学疗法。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003245. doi: 10.1002/14651858.CD003245.pub2.
5
Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy.腹腔镜胃底折叠术在缓解胃食管反流病（GERD）症状及停用抗反流药物治疗方面的有效性。
Surg Endosc. 2003 Aug;17(8):1200-5. doi: 10.1007/s00464-002-8910-y. Epub 2003 May 13.
6
Pathophysiology and treatment of gastro-oesophageal reflux disease.
Scand J Gastroenterol Suppl. 1989;165:7-12; discussion 27-8. doi: 10.3109/00365528909091225.